Atlas Trials

The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain

Clinical trial NCT03621423 · UNKNOWN

Trial details

NCT number
NCT03621423
Sponsor
Loewenstein Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hemiplegia, Spastic
Start date
2018-11-01
Primary completion
2020-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.